Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 152

1.

Association between heterozygosity for HFE gene mutations and hepatitis viruses in hepatocellular carcinoma.

Fracanzani AL, Fargion S, Stazi MA, Valenti L, Amoroso P, Cariani E, Sangiovanni A, Tommasini M, Rossini A, Bertelli C, Fatta E, Patriarca V, Brescianini S, Stroffolini T.

Blood Cells Mol Dis. 2005 Jul-Aug;35(1):27-32.

PMID:
15894495
2.

Mutations in the HFE gene and their interaction with exogenous risk factors in hepatocellular carcinoma.

Fargion S, Stazi MA, Fracanzani AL, Mattioli M, Sampietro M, Tavazzi D, Bertelli C, Patriarca V, Mariani C, Fiorelli G.

Blood Cells Mol Dis. 2001 Mar-Apr;27(2):505-11.

PMID:
11500061
3.

HFE C282Y heterozygosity in hepatocellular carcinoma: evidence for an increased prevalence.

Hellerbrand C, Pöppl A, Hartmann A, Schölmerich J, Lock G.

Clin Gastroenterol Hepatol. 2003 Jul;1(4):279-84.

PMID:
15017669
4.

Increased incidence of HFE C282Y mutations in patients with iron overload and hepatocellular carcinoma developed in non-cirrhotic liver.

Blanc JF, De Ledinghen V, Bernard PH, de Verneuil H, Winnock M, Le Bail B, Carles J, Saric J, Balabaud C, Bioulac-Sage P.

J Hepatol. 2000 May;32(5):805-11.

PMID:
10845668
5.

HFE mutations and chronic hepatitis C: H63D and C282Y heterozygosity are independent risk factors for liver fibrosis and cirrhosis.

Erhardt A, Maschner-Olberg A, Mellenthin C, Kappert G, Adams O, Donner A, Willers R, Niederau C, Häussinger D.

J Hepatol. 2003 Mar;38(3):335-42.

PMID:
12586300
6.

Mutations of the HFE gene in patients with hepatocellular carcinoma.

Cauza E, Peck-Radosavljevic M, Ulrich-Pur H, Datz C, Gschwantler M, Schöniger-Hekele M, Hackl F, Polli C, Rasoul-Rockenschaub S, Müller C, Wrba F, Gangl A, Ferenci P.

Am J Gastroenterol. 2003 Feb;98(2):442-7.

PMID:
12591066
7.

Lack of association between HFE gene mutations and hepatocellular carcinoma in patients with cirrhosis.

Boige V, Castéra L, de Roux N, Ganne-Carrié N, Ducot B, Pelletier G, Beaugrand M, Buffet C.

Gut. 2003 Aug;52(8):1178-81.

8.

Liver iron, HFE gene mutations, and hepatocellular carcinoma occurrence in patients with cirrhosis.

Nahon P, Sutton A, Rufat P, Ziol M, Thabut G, Schischmanoff PO, Vidaud D, Charnaux N, Couvert P, Ganne-Carrie N, Trinchet JC, Gattegno L, Beaugrand M.

Gastroenterology. 2008 Jan;134(1):102-10. Epub 2007 Oct 26.

PMID:
18061182
9.

HFE gene mutations in alcoholic and virus-related cirrhotic patients with hepatocellular carcinoma.

Lauret E, Rodríguez M, González S, Linares A, López-Vázquez A, Martínez-Borra J, Rodrigo L, López-Larrea C.

Am J Gastroenterol. 2002 Apr;97(4):1016-21.

PMID:
12003382
10.

Prevalence of common HFE and SERPINA1 mutations in patients with hepatocellular carcinoma in a Moroccan population.

Ezzikouri S, El Feydi AE, El Kihal L, Afifi R, Benazzouz M, Hassar M, Chafik A, Pineau P, Benjelloun S.

Arch Med Res. 2008 Feb;39(2):236-41. doi: 10.1016/j.arcmed.2007.09.006.

PMID:
18164971
11.

[The H63D mutation in the HFE gene is related to the risk of hepatocellular carcinoma].

Ropero P, Briceño O, López-Alonso G, Agúndez JA, González Fernández FA, García-Hoz F, Villegas Martínez A, Díaz-Rubio M, Ladero JM.

Rev Esp Enferm Dig. 2007 Jul;99(7):376-81. Spanish.

12.

Lack of association of primary iron overload and common HFE gene mutations with liver cirrhosis in adult Indian population.

Jain S, Agarwal S, Tamhankar P, Verma P, Choudhuri G.

Indian J Gastroenterol. 2011 Jul;30(4):161-5. doi: 10.1007/s12664-011-0109-5. Epub 2011 Aug 6.

PMID:
21822737
13.

Prevalence and clinical implications of HFE gene mutations (C282Y and H63D) in patients with chronic hepatitis B and C in Taiwan.

Mah YH, Kao JH, Liu CJ, Chen CL, Chen PJ, Lai MY, Chen DS.

Liver Int. 2005 Apr;25(2):214-9.

PMID:
15780041
14.

[HFE gene mutations, hepatic iron content, and histological severity in hepatitis C virus-induced chronic hepatitis].

Ladero JM, Ropero P, Ortega L, Taxonera C, González FA, López-Alonso G, Briceño O, Rodríguez-Agulló JL, González L, Villegas A, Díaz-Rubio M.

Rev Esp Enferm Dig. 2003 Dec;95(12):829-36. English, Spanish.

15.

Mutations of the HFE gene and the risk of hepatocellular carcinoma.

Racchi O, Mangerini R, Rapezzi D, Gaetani GF, Nobile MT, Picciotto A, Ferraris AM.

Blood Cells Mol Dis. 1999 Oct-Dec;25(5-6):350-3.

PMID:
10660482
16.

HFE gene mutations an Apulian population: allele frequencies.

Pietrapertosa A, Vitucci A, Campanale D, Palma A, Renni R, Delios G, Tannoia N.

Eur J Epidemiol. 2003;18(7):685-9.

PMID:
12952143
17.

Influence of mutation of the HFE gene on the progression of chronic viral hepatitis B and C in Moroccan patients.

Ezzikouri S, Rebbani K, Mostafa A, El Feydi AE, Afifi R, Brahim I, Kitab B, Benazzouz M, Kandil M, Nadifi S, Pineau P, Benjelloun S.

J Med Virol. 2011 Dec;83(12):2096-102. doi: 10.1002/jmv.22245.

PMID:
22012716
18.

Hemochromatosis and transferrin receptor gene polymorphisms in chronic hepatitis C: impact on iron status, liver injury and HCV genotype.

Gehrke SG, Stremmel W, Mathes I, Riedel HD, Bents K, Kallinowski B.

J Mol Med (Berl). 2003 Dec;81(12):780-7. Epub 2003 Oct 14.

PMID:
14557859
20.

An open population screening study for HFE gene major mutations proves the low prevalence of C282Y mutation in Central Italy.

Floreani A, Rosa Rizzotto E, Basso D, Navaglia F, Zaninotto M, Petridis I, DI Andrea O, Testa R, Marra M, Baldo V, Chiaramonte M.

Aliment Pharmacol Ther. 2007 Aug 15;26(4):577-86.

Supplemental Content

Support Center